Clinical Research Directory
Browse clinical research sites, groups, and studies.
Clinical Study to Evaluate the Efficacy of Febuxostat in the Treatment of Conservatively Managed Intracranial Hemorrhage Patients
Sponsor: Tanta University
Summary
To assess the effect of Febuxostat on clinical outcomes and biomarkers of oxidative stress and inflammation in patients with conservatively managed intracranial hemorrhage.
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
INTERVENTIONAL
Enrollment
46
Start Date
2025-11-20
Completion Date
2027-01-30
Last Updated
2026-07-14
Healthy Volunteers
No
Conditions
Interventions
Febuxostat 40 mg
Participants in this arm will receive Febuxostat at a dose of 40 mg orally once daily for a duration of three months, administered in addition to the standard traditional therapy for conservatively managed intracranial hemorrhage
Standard medical treatment
Participants in this arm will receive only the standard traditional medical guidelines and therapy for conservatively managed intracranial hemorrhage for a duration of three months
Locations (1)
Neurosurgery department Mansoura university hospitals
Al Mansurah, Dakahlia Governorate, Egypt